118 related articles for article (PubMed ID: 35073278)
21. LncRNA PITPNA-AS1 boosts the proliferation and migration of lung squamous cell carcinoma cells by recruiting TAF15 to stabilize HMGB3 mRNA.
Ren P; Xing L; Hong X; Chang L; Zhang H
Cancer Med; 2020 Oct; 9(20):7706-7716. PubMed ID: 32871048
[TBL] [Abstract][Full Text] [Related]
22. HMGB3 promotes the malignant phenotypes and stemness of epithelial ovarian cancer through the MAPK/ERK signaling pathway.
Ma H; Qi G; Han F; Gai P; Peng J; Kong B
Cell Commun Signal; 2023 Jun; 21(1):144. PubMed ID: 37328851
[TBL] [Abstract][Full Text] [Related]
23. SYT7 regulates the progression of chronic lymphocytic leukemia through interacting and regulating KNTC1.
Zhang W; Long J; Tang P; Chen K; Guo G; Yu Z; Lin J; Liu L; Zhan R; Xu Z
Biomark Res; 2023 Jun; 11(1):58. PubMed ID: 37280656
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-18 facilitates the stemness of gastric cancer by downregulating HMGB3 though targeting Meis2.
Zhang Y; Lin W; Jiang W; Wang Z
Bioengineered; 2022 Apr; 13(4):9959-9972. PubMed ID: 35416122
[TBL] [Abstract][Full Text] [Related]
25. SYT7 is a key player in increasing exosome secretion and promoting angiogenesis in non-small-cell lung cancer.
Liu X; Li R; Chen X; Yao J; Wang Q; Zhang J; Jiang Y; Qu Y
Cancer Lett; 2023 Nov; 577():216400. PubMed ID: 37774826
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients.
Li M; Cai Y; Zhao H; Xu Z; Sun Q; Luo M; Gu L; Meng M; Han X; Sun H
Tumour Biol; 2015 Jun; 36(6):4785-92. PubMed ID: 25647262
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA HOTTIP promotes hypoxia-induced glycolysis through targeting miR-615-3p/HMGB3 axis in non-small cell lung cancer cells.
Shi J; Wang H; Feng W; Huang S; An J; Qiu Y; Wu K
Eur J Pharmacol; 2019 Nov; 862():172615. PubMed ID: 31422060
[TBL] [Abstract][Full Text] [Related]
28. miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells.
Sharma P; Yadav P; Jain RP; Bera AK; Karunagaran D
Life Sci; 2022 Feb; 291():120268. PubMed ID: 34973275
[TBL] [Abstract][Full Text] [Related]
29. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
[TBL] [Abstract][Full Text] [Related]
30. Smad Ubiquitination Regulatory Factor 1 (Smurf1) Promotes Thyroid Cancer Cell Proliferation and Migration via Ubiquitin-Dependent Degradation of Kisspeptin-1.
Yan C; Su H; Song X; Cao H; Kong L; Cui W
Cell Physiol Biochem; 2018; 49(5):2047-2059. PubMed ID: 30244247
[TBL] [Abstract][Full Text] [Related]
31. HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/β-catenin pathway.
Zhang Z; Chang Y; Zhang J; Lu Y; Zheng L; Hu Y; Zhang F; Li X; Zhang W; Li X
PLoS One; 2017; 12(7):e0179741. PubMed ID: 28678825
[TBL] [Abstract][Full Text] [Related]
32. SOX9 and HMGB3 co-operatively transactivate NANOG and promote prostate cancer progression.
Xu Y; Xu M; Li X; Weng X; Su Z; Zhang M; Tan J; Zeng H; Li X; Nie L; Gong J; Chen N; Chen X; Zhou Q
Prostate; 2023 Apr; 83(5):440-453. PubMed ID: 36541373
[TBL] [Abstract][Full Text] [Related]
33. Targeting the High-Mobility Group Box 3 Protein Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin.
Mukherjee A; Huynh V; Gaines K; Reh WA; Vasquez KM
Cancer Res; 2019 Jul; 79(13):3185-3191. PubMed ID: 31061066
[TBL] [Abstract][Full Text] [Related]
34. Synaptotagmin-7, a binding protein of P53, inhibits the senescence and promotes the tumorigenicity of lung cancer cells.
Fei Z; Gao W; Xie R; Feng G; Chen X; Jiang Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647108
[TBL] [Abstract][Full Text] [Related]
35. Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.
Yamada Y; Nishikawa R; Kato M; Okato A; Arai T; Kojima S; Yamazaki K; Naya Y; Ichikawa T; Seki N
J Hum Genet; 2018 Feb; 63(2):195-205. PubMed ID: 29196733
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of SNHG16 alleviates the acute lung injury in sepsis rats through miR-128-3p/HMGB3 axis.
Sun J; Xin K; Leng C; Ge J
BMC Pulm Med; 2021 Jun; 21(1):191. PubMed ID: 34092219
[TBL] [Abstract][Full Text] [Related]
37. Circ_CLIP2 promotes glioma progression through targeting the miR-195-5p/HMGB3 axis.
Xiao B; Lv SG; Wu MJ; Shen XL; Tu W; Ye MH; Zhu XG
J Neurooncol; 2021 Sep; 154(2):131-144. PubMed ID: 34357490
[TBL] [Abstract][Full Text] [Related]
38. Circular RNA circFOXO3 facilitate non-small cell lung cancer progression through upregulating HMGB3 via sponging miR-545-3p/miR-506-3p.
Yang M; Zheng E; Ni J; Xu X; Jiang X; Zhao G
Tissue Cell; 2022 Apr; 75():101702. PubMed ID: 35038619
[TBL] [Abstract][Full Text] [Related]
39. MiR-27b is epigenetically downregulated in tamoxifen resistant breast cancer cells due to promoter methylation and regulates tamoxifen sensitivity by targeting HMGB3.
Li X; Wu Y; Liu A; Tang X
Biochem Biophys Res Commun; 2016 Sep; 477(4):768-773. PubMed ID: 27363334
[TBL] [Abstract][Full Text] [Related]
40. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
